← Back to Search

Telehealth Care-Coordination for Mental Illness (BHH Trial)

N/A
Recruiting
Led By George Unick
Research Sponsored by University of Maryland, Baltimore
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Prescribed psychiatric medications
Aged 18 to 80 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up two years prior to study enrollment to at least one year after study enrollment.
Awards & highlights

BHH Trial Summary

This trial will test an expanded set of telehealth care-coordination services that can be used to address the broad health needs of individuals diagnosed with SMI living in community settings and supported by community mental health agencies.

Who is the study for?
This trial is for adults aged 18-80 with Serious Mental Illness (SMI) who are prescribed psychiatric medications and receive services from a participating community mental health agency. They must be willing to have the Medherent device in their residence, either as current users or new participants.Check my eligibility
What is being tested?
The study tests the Medherent medication management platform along with additional telehealth care-coordination services aimed at improving health outcomes for individuals with SMI living in community settings.See study design
What are the potential side effects?
Since this trial involves a telehealth service rather than a drug, traditional side effects aren't expected. However, there may be challenges like adapting to technology use and privacy concerns.

BHH Trial Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below
Select...
I am taking medication for a mental health condition.
Select...
I am between 18 and 80 years old.
Select...
I am unable to understand and consent to the study.

BHH Trial Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~two years prior to study enrollment to at least one year after study enrollment.
This trial's timeline: 3 weeks for screening, Varies for treatment, and two years prior to study enrollment to at least one year after study enrollment. for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Change in Health Service Costs
Consumer Satisfaction STAR-P
Diabetes control as reported hemoglobin A1c levels
+3 more

BHH Trial Design

3Treatment groups
Experimental Treatment
Active Control
Group I: New MedherentExperimental Treatment1 Intervention
Group using Medherent Device with added interventional components.
Group II: Usual CareActive Control1 Intervention
Usual Care: no intervention elements.
Group III: Existing MedherentActive Control1 Intervention
Group using the Medherent Device with no added intervention components.

Find a Location

Who is running the clinical trial?

University of Maryland, BaltimoreLead Sponsor
688 Previous Clinical Trials
374,356 Total Patients Enrolled
8 Trials studying Mental Disorders
775 Patients Enrolled for Mental Disorders
George UnickPrincipal InvestigatorUniversity of Maryland

Media Library

Medherent Clinical Trial Eligibility Overview. Trial Name: NCT05160701 — N/A
Mental Disorders Research Study Groups: Usual Care, Existing Medherent, New Medherent
Mental Disorders Clinical Trial 2023: Medherent Highlights & Side Effects. Trial Name: NCT05160701 — N/A
Medherent 2023 Treatment Timeline for Medical Study. Trial Name: NCT05160701 — N/A

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

Does this research protocol currently permit enrollees?

"According to the clinicaltrials.gov listing, this study is currently recruiting patients and has been active since May 9th 2022 following its last edit in July 15th 2022."

Answered by AI

What is the overall population size actively participating in this research endeavor?

"Affirmative. The information on clinicaltrials.gov confirms that recruitment is currently underway for this study, which was initially posted on May 9th 2022 and recently modified on July 15th 2022. Altogether, 300 people need to be recruited from a single facility."

Answered by AI

Can persons under 45 partake in this clinical trial?

"This clinical trial is seeking participants who are of legal age or older, and no more senior than 88 years old."

Answered by AI

What types of participants are ideal for this trial?

"Qualified participants for this trial must suffer from a mental illness and be between 18-88 years old. This research project is looking to enroll ~300 individuals."

Answered by AI

Who else is applying?

What state do they live in?
North Carolina
Alabama
How old are they?
18 - 65
What site did they apply to?
University of Maryland
What portion of applicants met pre-screening criteria?
Met criteria

How responsive is this trial?

Typically responds via
Email
Recent research and studies
clinicaltrials.govStudy
Bringing Health Home
George Unick 2022. "Bringing Health Home". ClinicalTrials.gov. https://clinicaltrials.gov/ct2/show/NCT05160701.
~44 spots leftby Sep 2024
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top